Page 313 - v11i4
P. 313

International Journal of Bioprinting                                 3D scaffold prevents tendon ossification







































            Figure 5. Cell viability and migration capacity in SF and SF–HPC tissue-engineered Achilles tendon scaffolds. (A, B) representative live/dead staining
            images of cells in SF and SF–HPC scaffolds after 72 h of culture. (C) Quantitative analysis of cell viability at 72 h. (D, E) Representative images of Transwell
            migration assay after 36 h. (F) Quantification of migrated cells per field in Transwell assays after 36 h. (G) Scratch assay images showing cell migration at
            0, 12, 24, and 36 h. Scale bars: (A) 50 μm, (B) 50 μm, (D) 100 μm, (E) 100 μm, (G) 500 μm; magnifications: (A) 200×, (B) 200×, (D) 500×, (E) 500×, (G)
            100×. n = 3; *p < 0.05, **p < 0.01. Abbreviations: HPC, hydroxypropyl cellulose; SF, silk fibroin.


            groups  (Figure  5G).  The SF–HPC group  demonstrated   by PCR at weeks 2 and 4. The results demonstrated that
            a narrower scratch gap and stronger cell migration   the expression of the tenogenic marker  Scx in the SF–
            capability compared to the SF group. Cell migration within   HPC group was significantly higher than in the SF group
            scaffolds is critical for scaffold–host tissue integration.    at both time points. Conversely, the expression levels of
                                                         55
            Migratory cells infiltrate the defect site and fill the interface   chondrogenic  (Sox9)  and  osteogenic  (Bmp2)  markers
            between the scaffold and host tissue, thereby promoting   were significantly lower in the SF–HPC group compared
            seamless integration.                              to the SF group (Figure 6B–D). These findings indicate
                                                               that SF–HPC scaffolds preferentially promote tenogenic
               To evaluate cell proliferation within the scaffolds, a
            CCK-8 assay was performed. The results showed gradual   differentiation of TSPCs.
            cell proliferation in both SF and SF–HPC scaffolds over   The tenogenic differentiation capacity of TSPCs
            time. At 12, 24, and 72 h, the SF–HPC group exhibited   is a central driver of functional tissue regeneration.
            significantly higher proliferative activity compared to the   Tenogenically differentiated TSPCs mature into tenocytes,
            SF group (Figure 6A). Cell proliferation is a pivotal factor   which directly synthesize and assemble type I collagen
            in determining scaffold functionality and regenerative   fibers—the critical structural component responsible for
            efficiency.  Proliferatively active TSPCs rapidly colonize   the mechanical strength of Achilles tendons.  Tenocyte
                                                                                                    57
                    56
            the scaffold surface, migrate to the defect site, and secrete   activity governs collagen fiber alignment, density, and
            extracellular matrix components such as collagen, thereby   crosslinking, thereby determining the structural integrity
            forming a structural framework for neo-tendon tissue and   of regenerated tendon tissue. 58
            accelerating Achilles tendon repair.                  In the pathological progression of HO following
               To assess the tenogenic differentiation capacity of   Achilles tendon injury, SOX-9 and BMP2 are key
            TSPCs  within  the  scaffolds,  SF  and  SF–HPC  scaffolds   molecular drivers of aberrant bone formation.  SOX-
                                                                                                       59
            seeded with TSPCs were cultured  in vitro and analyzed   9, a master transcriptional regulator of chondrogenesis,

            Volume 11 Issue 4 (2025)                       305                            doi: 10.36922/IJB025210203
   308   309   310   311   312   313   314   315   316   317   318